Volunteer s death in Bhopal not related to our vaccine: Bharat Biotech PTI
Updated : Jan 10, 2021, 10:06 am IST
The volunteer was reported to be healthy in all the site follow-up calls post seven days of his dosing, the vaccine maker said
There are several factors that can cause an adverse event during a clinical trial, including the patient s underlying disease, other pre-existing conditions or any other unrelated occurrence like an accident, Bharat Biotech said. (Representational Image: AFP)
Volunteer s death in Bhopal not related to our vaccine: Bharat Biotech
New Delhi: Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.
ANI | Updated: Jan 09, 2021 20:24 IST
New Delhi [India], January 9 (ANI): After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the site follow up calls post seven days of his dosing.
With regard to reports of a death in Phase III trials, we would like to state that a volunteer passed away on December 21, 2020, and the death was reported to the People s College of Medical Sciences and Research Centre by the son of the deceased, Bharat Biotech stated.
Volunteer s Death Unrelated To Covaxin: Bharat Biotech We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded, the vaccine major noted. PTI outlookindia.com 2021-01-09T20:56:07+05:30
After the death of a 42-year-old volunteer in Bhopal, who took a dose of Covaxin in the clinical trial of Bharat Biotech s Covaxin, further spurred controversy over the emergency approval of the firm s covid vaccine, Bharat Biotech denied that the vaccine was the cause of the volunteer s death.
Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.
Volunteer s death in Bhopal not related to vaccine, may be of poisoning: Bharat Biotech
India
Published: Saturday, January 9, 2021, 20:43 [IST]
New Delhi, Jan 09: Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.
Representational Image As per the post-mortem report issued by the Gandhi Medical College, Bhopal that the site received from the Bhopal Police, the probable cause of death was due to cardio respiratory failure as a result of suspected poisoning and the case is under police investigation as well, the Hyderabad-based firm said in a statement.